
According to the USFDA, a VAI classification indicates that objectionable conditions were found, but no regulatory action is recommended
Aurobindo Pharma on Thursday said it has received an establishment inspection report with a satisfactory Voluntary Action Indicated (VAI) classification from the US health regulator for the Andhra-ba… [+835 chars]









